1. An in vitro reconstructed normal human corneal tissue model for corneal drug delivery studies of ophthalmic formulations. (16th October 2015) Authors: Kaluzhny, Y.; Letasiova, S.; Kinuthia, M.; d'Argembeau-Thornton, L.; Karetsky, V.; Hayden, P.; Klausner, M. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of drug metabolizing enzymes, transporters and permeation in a human organotypic corneal tissue model. (10th October 2018) Authors: Kaluzhny, Y.; Kinuthia, M.; Truong, T.; Lapointe, A.; Klausner, M.; Letasiova, S.; Hayden, P. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P12-52 Evaluating ocular side effects of systemic medications utilizing the in vitro reconstructed human corneal epithelial tissue model. (1st September 2022) Authors: Kaluzhny, Y.; Kinuthia, M.; Klausner, M.; Armento, A.; Karetsky, V. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗